ATLAS News · Companies

Eli Lilly Partners With Hims & Hers for Direct Weight-Loss Drug Delivery

Published November 6, 2026 · 3 sources

Benzinga and BigGo Finance report Eli Lilly is teaming up with telehealth company Hims & Hers to deliver weight-loss drugs directly to patients.

What happened

Benzinga reports that telehealth company Hims & Hers has partnered with Eli Lilly to offer direct delivery of weight-loss drugs. BigGo Finance also reports the tie-up, describing it as Lilly teaming up with the Hims platform.

BigGo Finance frames the deal as part of a growing battle over cash-pay channels for weight-loss medicines. The sources provided do not give financial terms or a launch timeline.

Separately, ad-hoc-news.de reports that Eli Lilly shares traded at 1,229.60 euros on Friday, below the previous Xetra close. The outlet's description links this to strong demand and deal-related charges.

Context

Telehealth platforms have become an increasingly visible route for patients to obtain prescription weight-loss treatments, and drugmakers have been exploring direct-to-patient sales options.

Why it matters

The partnership shows how Eli Lilly is working on direct-to-consumer distribution for its weight-loss drugs, a channel that may matter to both companies.

Stocks in this story

Price changes are shown for the trading day of the story and are a coincidence in time, not proof that the news caused them. Figures are ATLAS data from our database.

Eli LillyLLY

+0.04%

Healthcare · NYSE

Latest price during the session: $1,365.28+0.04% vs. previous close ($1,364.73)
Fair value (ATLAS): $665.31Fair range: $511.11 to $866.04The price ($1,365.28) is 105.2% above that figure.
Chance of a rise in 1 month: 50%Probability of closing higher than today within 21 sessions.Normal range: half of the scenarios end between $1,284.74 and $1,452.46; 9 in 10, between $1,152.32 and $1,619.36.

See the full ATLAS analysis of Eli Lilly →

Closing prices, fair value and probabilities: ATLAS own data. How we calculate fair value.

Sources

ATLAS writes its own summaries from the reporting of these outlets. Each link opens the original publisher.

Eli Lilly stock slips as strong demand meets deal charges · ad-hoc-news.de · November 6, 2026
Telehealth Giant Hims & Hers Partners with Eli Lilly for Direct Weight Loss Drug Delivery · Benzinga · November 6, 2026
Eli Lilly Teams Up With Hims Platform for Direct Delivery of Weight-Loss Drugs as Cash-Pay Channel Battle Heats Up · BigGo Finance · November 6, 2026

Latest market news · Markets today on ATLAS · Eli Lilly

What you get with ATLAS

Create my ATLAS account →

Fair value, probabilities and earnings for every stock. Free account, no card. Information, not advice.

Information, not advice. This content is informational and is not an investment recommendation or an offer to buy or sell securities. ATLAS estimates come from statistical models using public data, can be wrong, and past performance does not guarantee future results. Disclaimer